We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Thinksmart Limited | LSE:TSL | London | Ordinary Share | AU000XINEAE8 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 28.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/12/2004 19:40 | Looking good! | phoenixbird | |
22/12/2004 14:50 | Another important development today: FDA approval for the use of Permacol for certain types of abdominal repair: | diogenesj | |
02/12/2004 08:16 | Accidentally half-mentioned in The Times overnight editions.. but not actually named! The paper described yesterday's news affecting BQE and HCEG, describing the latter as rising 10p to 185p - which of course is what TSL did, not HCEG. Sounds like they were previously about to mention TSL and switched stories. | m.t.glass | |
01/12/2004 11:49 | Good rise today, on the announcement of a Teach-in for analysts and investors (I'm sorry to say I was not invited myself, but I'm not sure I have the stomach for it anyway): 1 December 2004 Tissue Science Laboratories Plc TSL Teach-in For Analysts and Investors Aldershot, UK - Tissue Science Laboratories plc (LSE: TSL), the medical devices company specialising in tissue replacement and repair, is holding a teach-in for analysts and investors today. In addition to the Company, two guest speakers will be attending and speaking at the meeting - Professor Norman Williams of the London Hospital and St Bartholomew's and Dr Paul Sibbons of the Northwick Park Institute of Medical Research. Professor Williams will be speaking about Permacol's(R) use in colorectal surgery and stoma repair, from the surgeon's point of view. Dr Sibbons will be speaking on the potential new applications of Permacol(R) in orthopaedic and vascular surgery. Other topics covered throughout the morning will include an in-depth view of the manufacturing process and science behind TSL's collagen sheet material Permacol (R), and the current sales operations in General Surgery (complex and recurring hernia repair) in North America and Europe. Potential future uses of the technology in other surgical areas will also be discussed. The teach-in will take place at the London Stock Exchange, 10 Paternoster Square, London, EC4M 7LS and will commence at 9:30am. For those unable to attend, presentation slides will be available on request. | diogenesj | |
21/11/2004 15:51 | Nice and quiet here. I'd like to see the charts at the top of the thread. Is Oneliner still about, and if so can you put them in, please? | diogenesj | |
12/7/2004 11:13 | Big Spender- Tissue Science Laboratories PLC, the medical devices company specialising in human tissue replacement and repair, said chief executive Martin Hunt bought 6,250 shares in the company, equivalent to a 0.026 pct stake, at 160 pence per share each. | williemanjaro | |
05/7/2004 11:36 | A 32,000 buy this a.m? Also saw this mention in the Sunday Times Malta Edition. Tissue Science Laboratories, which produces unique tissue implants, was highlighted last January. This is a loss-making medical devices company and has a higher-than-average risk profile. However, it also has tremendous growth potential. The company is very sensitive to dollar weakness since most of its sales are in the US. This is an especially important consideration while it is still loss making. We are bearish on the dollar long term but also think that in that same time period sales growth will more than compensate. We remain happy to hold for the long term. The shares have risen from 105p to 152p, a gain of 45%. Curmi & Partners- | williemanjaro | |
24/6/2004 11:24 | wow............someo | muscapharoah | |
22/6/2004 13:45 | Errrr-is anyone alive here! Hold the press-we have a 2p tick up here-LOL Suppose no news until September-but have just noted this. RNS Number:7303Z Tissue Science Laboratories PLC 14 June 2004 For immediate distribution 14 June 2004 APPOINTMENTS OF FINANCIAL ADVISORS AND BROKERS Tissue Science Laboratories plc (LSE:TSL) ('Company'), the medical devices company specialising in human tissue replacement and repair, is pleased to announce the appointments of Code Securities Limited as the Company's financial advisor and joint stockbroker, and Altium Capital Limited as the Company's nominated advisor and broker. The appointments become effective immediately. | williemanjaro | |
15/4/2004 10:30 | Yes. You only need to buy 2k shares and the price is hiked up as there are only 2 MM's on this one. Of course if you wanna get out in a hurry it won't be easy as the stock is tightly controlled but have you noticed that the price holds even when the market drops. Buy and hold and the rewards will be reaped in 2005 when the company becomes profitable. Projected earnings for 2005 are 11.78p and for 2006 15.27p. | phoenixbird | |
15/4/2004 09:54 | Nice summing up there phoenixbird. I can add little to the discussion here-.....yet-.....but a top analyst friend mentioned TSL to me last December. As he put it- the company has terrific product and distribution partners. Of the eight companies mentioned to me, TSL was one of his top two picks. Wish I`d listened to him then! Still- I bought in today as -one -I have the cash and- two-the story looks better than ever. Delayed buy still to show I see ;-0 | williemanjaro | |
14/4/2004 10:56 | It would be silly to try and predict what the share price is likely to be in the future but one thing is for sure, sales growth is imminent and the company is rapidly heading towards profitability. The company's Permacol product is patented worldwide and is licensed to CR Bard in the USA....... a multi billion dollar company with sales crews in the US and Europe. The latest deal with Zimmer is in itself a blockbuster potential with huge potential sales. The AGM for TSL is in June.....in the meantime check out the company's website for product info and check out the web sites of CR Bard and Zimmer...huge upside on this one. This is a growth company and is for those who are prepared to hold for another 12 months at least. The Permacol product is unique and multi faceted...there is nothing like it on the market! | phoenixbird | |
07/4/2004 19:44 | been told it could go a lot higher now they have a salesforce of 40 in the US. 400% production capacity increase now may be not enough if it takes off. | whitebicycle | |
07/4/2004 08:59 | Does anyone have a view on the potential of the share here? Doubled since Nov and I've got £3 in mind. | muscapharoah | |
06/4/2004 09:00 | Just thought I'd update the thread, still on the watchlist. | whitebicycle | |
01/3/2004 17:14 | could it be as straight forward as www.codesecurities.c | muscapharoah | |
01/3/2004 08:36 | Does anyone know the website address of Code Securities? | xumii | |
27/2/2004 17:51 | shouldn't bring the price down as the placing is purely for institutions. This is one is definately a hold position | phoenixbird | |
27/2/2004 15:17 | I'll keep an eye on this one I think | turbocharge | |
27/2/2004 08:58 | Your previous post says it all TurboCharge, it is for institutions, there will be some dilution but should accelerate growth. Thanks for the post. | whitebicycle | |
26/2/2004 18:01 | Does anybody know any more about the placing - is it just for institutions, and at 120p, is this going to drag the price down? TurboCharge | turbocharge | |
26/2/2004 11:20 | Still holding. | whitebicycle | |
26/2/2004 10:54 | Results announced today. I'd be interested in peoples views about this one. | muscapharoah |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions